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Aims:  The objective of our study was to perform the routine analysis of bronchoscopically obtained 
tracheal samples to determine the appearance and relative distribution of cytokines and 
antimicrobial proteins in patients with post-intubation tracheal stenosis (PITS). 
Study Design:  Retrospective. 
Place and Duration of Study:  Rīga Stradiņš University, Institute of Anatomy and Anthropology, 
Pauls Stradiņš Clinical University Hospital, between May 2014 and May 2015. 
Methodology:  Five patients with PITS were involved in this study. Tissue samples were obtained 
by bronchoscopy from the upper part of trachea, then proceeded for routine histological staining 
with hematoxylin and eosin. Interleukine-1 (IL-1), interleukine-10 (IL-10) and tumor necrosis factor 
alpha (TNFα), as well as beta defensin-2 (β def-2) were detected by use of immunohistochemistry 
(IMH) method. The number of immunoreactive (positive) structures was graded semi-quantitatively. 











Results:  Squamous metaplasia, inflammatory cell infiltration and formation of granulation tissue 
were observed in all cases. Significant expression of IL-10 and β def-2 was seen as various 
number of immunoreactive structures in tracheal tissue. Only few scattered IL-1 and TNFα positive 
macrophages were found in part of cases. 
Conclusions:  The leading role in pathogenesis of post-intubation tracheal stenosis is assumed to 
be the chronic inflammation, fibrous scarring, as well as the remodeling of tracheal wall due to the 
ischemia. Compensatory expression of antimicrobial peptide β def-2 and anti-inflammatory 
cytokine IL-10 indicates the intense local tissue defense reactions. TNFα and IL-1 are not among 
the most significant factors in pathogenesis of PITS. 
 
 




The most common reasons for the non-malignant 
obstruction of central airways (trachea, as well as 
primary bronchi) are intubation and tracheostomy 
[1] or combination of both [2], which are 
considered as iatrogenic causes. The incidence 
of post-intubation tracheal stenosis diagnosed in 
patients with prolonged artificial ventilation varies 
from 1% to 2% of patients requiring treatment, 
and 10% to 22% due to the presence of clinical 
signs and symptoms [3], in total estimating 4.9 
cases per million per year [4].  
 
Post-intubation tracheal stenosis is a 
complication of endotracheal intubation using 
cuffed intubation tube, which usually occurs at 
the site of the contiguity of cuff and the tracheal 
wall in the upper part of the trachea (in the 
subglottic region) [5]. The following factors could 
predispose the development of post-intubation 
tracheal stenosis: prolonged and/or traumatic 
intubation, history of intubation, previous 
tracheotomy, use of high dose corticosteroids, 
advanced age, female gender, severe respiratory 
failure, severe gastroesophageal reflux disease 
(GERD), concomitant autoimmune diseases, 
sleep apnea–hypopnea syndrome, local radiation 
therapy [5].  
 
The morphopathogenesis of post-intubation 
tracheal stenosis includes the development of 
fibrous tissue along with the local ischemia 
mainly [6-10].  
 
The pseudostratified ciliated epithelium, which 
normally lies the trachea, is often replaced by 
stratified squamous epithelium. Sometimes 
keratinization and flattening of the surface cells is 
present [11]. Similar findings were observed in 
animal (rabbit) model [12].  
 
Besides the scarring fibrosis and squamous 
metaplasia, the mucosa demonstrates the 
ulceration sites and the wrinkling of mucosal 
layer and cartilage, as well as atrophic glands 
[9,13].  
 
Inflammatory cell infiltrations containing 
lymphocytes and plasma cells, but mostly 
neutrophils could be found both in mucosa and 
submucosa [14-16].  
 
The cruicial player in the pathogenesis of post-
intubation tracheal stenosis appears to be also 
the local inflammatory responses to the injury. 
Initial inflammatory phase of wound healing 
includes the release of the inflammatory signals 
from different cell types, not always derived from 
the immune system, that further enchances the 
accumulation of immunological cells 
(macrophages, granulocytes, lymphocytes) in 
tissue of exact organ. Inflammatory signals 
enchances the ingrowth of fibroblasts, 
depositions of connective tissue components, 
angiogenesis and the formation of granulation 
tissue [14,17].  
 
The presence of immune cells accumulated in 
the tissue occur due to the different cytokine 
expression, so the cytokine interleukine-1 (IL-1) 
family have autoinflammatory and autoimmune 
properties, but IL-1 itself is a proinflammatory 
cytokine. IL-1 possesses also the regulatory 
function on innate immunity and inflammation by 
amplifying the humoral innate immunity and the 
resistance to infections, regulating tissue 
damage, recruiting leukocytes, prolonging the 
lifespan and stimulating the functions of 
neutrophils and macrophages [18,19].  
 
Other interesting cytokine is IL-10. IL-10 inhibits 
cytokines associated with cellular imunity and 
allergic inflammation while stimulating humoral 
responses [20] and promotes the growth of the B 
lymphocytes [18,21]. Primary sources of IL-10 
are regulatory T cells, however, the most 











monocytes and B lymphocytes. The dual nature 
of IL-10 have been described, firstly, IL-10 
inhibits the synthesis of proinflammatory 
cytokines, therefore this cytokine has anti-
inflammatory potential. Secondly, due to the 
activated immunogenic cells, IL-10 could 
promote the inflammation processes. However, 
IL-10 works as anti-inflammatory cytokine 
blocking pro-inflammatory and inflammatory 
signaling [18,21,20].  
 
Tumor necrosis factor alpha (TNFα) is a potent 
cytokine with wide activity of pro-inflammatory 
properties [18,22]. TNFα have a wide spectrum 
of activities. It promotes the degranulation of 
neutrophils, previously of what the chemotaxis of 
neutrophils could be observed. TNFα also 
activates macrophages to excrete matrix 
metalloproteinases (MMPs), as well as promotes 
the transcription of pro-inflammatory genes. 
TNFα induces several cytokines, for example, IL-
1 and IL-6 [23]. 
 
Beta defensin-2 (β def-2), an antimicrobic 
protein, prevents the skin and mucosa in 
respiratory, genitourinary, gastrointestinal 
systems from bacterial infections, therefore 
works as effectors of innate imunity and 
enchances the antigen specific humoral and 
cellular imunity [24]. β def-2 is a great example of 
defensins being activated by bacterial products 
and pro-inflammatory cytokines, which is 
released during the inflammatory response in 
normal tissue [25]. β def-2 is active against 
several Gram-negative bacteria and works 
synergically with antibacterial proteins, for 
example, lysozyme and lactoferrin. In 
vertebrates, β def-2 works not only as microbicid 
agent of innate immunity, but also promotes 
adaptive immunity, promotes the chemotactic 
recruitment of monocytes, macrophages, 
neutrophils and immature dendritic cells. β def-2 
also stimulates the migration, proliferation of 
endothelial cells [26]. 
 
Previously described pathological findings– 
fibrous scarring, development of granulation 
tissue, squamous metaplasia, immune cell 
infiltration due to the ischemia at the site of 
cuffed tube – can not be seen exclusively, 
therefore exact local mechanisms, intercellular 
interactions between different cell types must be 
analyzed for the understanding of complex 
pathological events found in post-intubation 
tracheal stenosis. Intercellular signaling in form 
of cytokine expression must be investigated to 
find specific pathogenetic stepways or how 
exactly the cuff pressure could lead to tracheal 
stenosis. 
 




The tissue was obtained from five patients      
(age 28 to 70) with post-intubation tracheal 
stenosis at Pauls Stradiņš Clinical University 
Hospital within a period of time in year 2013. 
Diagnosis of post-intubation tracheal stenosis 
was confirmed during the bronchoscopy, which 
was indicated for patients due to the clinical 
status. In all cases material was taken at the 
upper part of trachea from patients with 
prolonged intubation. The extension of tracheal 
stenosis evaluated through bronchoscope varies 
from 50% to 70% of the tracheal lumen; the 
length of fibrous tissue varies from 2 to 3 cm. 
The cause of original intubation was following:  
 
• Patient 1: acute pulmonary artery 
thromboembolism, myocardial infarction; 
• Patient 2: diabetic ketoacidosis; 
• Patient 3: acute pancreatitis;  
• Patient 4: head injury;  
• Patient 5: multiple trauma.  
 
All clinical information about the patients is 
summarized in Table 1. Patients with severe 
respiratory failure, severe GERD, concomitant 
autoimmune diseases, sleep apnea–hypopnea 
syndrome, local radiation therapy and 
administration of high-dose corticosteroids were 




1) Soft tissue specimens of 1-10 mm3 were 
taken under control of bronchoscope within 
local anaesthesia (submucosal 
administration on 1-2 mL of 1% lidocaine 
solution).  
2) The mixture of 2% formaldehyde and 0,2% 
picric acid in 0,1 M phosphate buffer (ph 
7,2) was used for tissue fixation. 
Afterwards tissue samples were rinsed in 
Thyroid solution, containing 10% sucrose 
for 12 hours, then were embedded into 
paraffin. Six to seven micrometers (µm) 
thin tissue sections were cut. 
3) Routine histological staining with 
hematoxylin and eosin was used for each 











4) Sections were proceed for detection of 
cytokines IL-1α, IL-10, TNFα and defensin 
β def-2 by use of biotin-streptavidin 
immunohistochemistry (IMH) method [27]. 
The characteristics of primary antibodies 
were following: 
 
• IL-10 (code: P22301, rabbit, work dilution 
1:400, BioSite),  
• TNFα (code: sc-52250, mouse, work 
dilution 1:100, Santa Cruz 
Biotechnology, INC),  
• IL-1α (code: sc-9983, mouse, work 
dilution 1:50, Santa Cruz Biotechnology, 
INC),  
• β defensin-2 (code: 015263, goat, work 
dilution 1:100, R&D Systems). 
5) The samples were examined under Leica 
DC 300F camera microscope for 
conventional histological picture. The 
relative number of positive 
immunohystochemical structures was 
graded semi-quantitatively [28,29]. The 
following scale of semi-quantitative method 
was used, counting the immunoreactive 
(positive) structures seen in visual field: 0 – 
no positive structures, 0/+ – occasional 
positive structures, + – few positive 
structures, +/++ – few to moderate number 
of positive structures, ++ – moderate 
number of positive structures, ++/+++ – 
moderate number to numerous positive 
structures, +++ – numerous positive 
structures, +++/++++ – numerous to 
abundance of positive structures, ++++ – 
abundance of positive structures seen in 




3.1 Routine Morphology 
 
The squamous metaplasia of tracheal epithelium 
(stratified squamous epithelium instead of 
pseudostratified ciliated epithelium) was found in 
all tissue specimens (Fig. 1). Moreover, the 
irregular thickening of basal membrane was seen 
in one case. Also numerous infrequent infiltration 
regions of inflammatory cells (macrophages, 
neutrophils, lymphocytes) were found in mucosa 
and submucosa of all tissue specimens (Fig. 2), 
however, intraepithelial infiltrations were not 
present. The granulation tissue with various 
amounts has been found in submucosa of all 
cases, showing well-formed connective tissue 
with the presence of numerous blood vessels. 
Prominent connective tissue fiber bundles with 
fibroblasts and morphologically modified 
fibroblasts, as well as sclerotized blood vessels 




Fig. 1. Note the squamous metaplastic epithelium in  tracheal mucosa of 28 years old male. 






























1 66 Female Prolonged 
intubation 
7 Yes No Yes Yes 
2 69 Male Prolonged 
intubation 
5 No 15 pack 
years 
Yes Yes 
3 70 Male Prolonged 
intubation 
7 No 20 pack 
years 
Yes Yes 
4 28 Male Prolonged 
intubation 
6 No 6 pack 
years 
No No 
5 29 Male Prolonged 
intubation 






Fig. 2. Note the abundance of inflammatory cells (m ainly neutrophils (arrow), but also 
lymphocytes) in the tracheal submucosa of 69 years old male. Hematoxylin and eosin, X400  
 
3.2 Immunohistochemistry  
 
The tissue demonstrated a moderate number 
(„++”) to abundance („++++”) of IL-10 positive 
inflammatory cells (macrophages, neutrophils, 
lymphocytes) both in mucosa and submucosa. 
Also few to abundance of fibroblasts (including 
modified fibroblasts), epithelial and endothelial 
cells for this cytokine were observed in tissue. In 
summary, the prominent expression of IL-10 was 
seen as numerous immunoreactive structures in 
both mucosal and submucosal layers of trachea 
(Table 2). 
 
Moderate number („++”) to abundance („++++”) 
of β def-2 positive structures were found in all 
cases: inflammatory cells (mostly neutrophils), 
fibroblasts, epithelial cells (Figs. 3 and 4). 
Moderate („++”) number of β def-2 positive 
glandulocytes in submucosal tracheal glands 












Table 2. Semiquantitative distribution of immunorea ctive (positive) structures in the tissue of 
patients with post-intubation tracheal stenosis 
 
Factors/ Patients  IL-10 β def -2 
e f i c e f i c 
1 ++ + +++ +++ ++ +++ 
2 0 + ++ 0 ++ +++/++++ 
3 ++++ +++ +++ +++ 0 +++ 
4 ++ +/++ +++ +++/++++ +++ +++ 
5 +++ +++ ++ ++ 0 +++ 
"0" – no positive structures seen in the visual field, "0/+" – occasional positive structures seen in the visual field, 
"+" – few positive structures seen in the visual field, "+/++" – few to moderate number of positive structures seen 
in the visual field, "++" – moderate number of positive structures seen in the visual field, "++/+++" – moderate 
number to numerous positive structures seen in the visual field, "+++" – numerous positive structures seen in the 
visual field, "+++/++++" – numerous to abundance of positive structures seen in visual field, "++++" – abundance 





Fig. 3. Arrows indicate the numerous β defensin-2-containing inflammatory cells and  
moderate number of β def-2-positive fibroblasts in tracheal submucosa o f 28 years old male.  
β defensin-2 IMH, X400 
 
Only occasional („0/+”) TNFα and IL-1 positive 
scattered macrophages were found in two cases 
(Fig. 5). In three cases tracheal tissue samples 
were observed as TNFα and IL-1 negative due to 
the none of positive structures observed in the 




From all the factors predisposing the occlusion of 
tracheal wall capillaries and consecutive 
ischemia caused by the prolonged intubation with 
cuffed tube [5], we found smoking, 
cardiovascular disease and diabetes to be 
possible coexisting contributory factors in the 
development of post-intubation tracheal stenosis.  
 
Our results show fibrotic tissue seen as 
adhesions located mostly in mucosa and 
submucosa, containing large amount of 
fibroblasts and components of extracellular 
matrix, as well as modified fibroblasts in two 
specimens, assuming this is the most important 
cause of bronchoscopically detected tracheal 











pathological events – scarring or cicatrization, 
web like fibrosis leading to local stricture – take 
place at previous necrotic site not only within 
mucosa, but also deeper in submucosa of 
tracheal wall [8]. Histological research of fibrosis 
reveal significant changes in in all layers of the 
tracheal wall [14]. Immunohistochemistry (IMH) 
investigation also reveals a strong martix 
associated subepithelial expression of 
transforming growth factor beta (TGF-β), which is 
one of the strongest inducers of myofibroblast 
differentiation and maturing, and is a mitogen to 
immature fibroblasts [30], as well as α-smooth 
muscle actin (α-SMA) for myofibroblast detection 
and collagen Type I was used to investigate the 
tissue of tracheal stenosis. Significant increase of 
collagen Type I deposits and intense web-like 
network of spindle shaped α-SMA positive cells 
were found in the subepithelial layer, suggesting 
that tracheal wall thickening found in post-
intubation tracheal stenosis is related to 
myofibroblast activation which afterwards 
arranges collagen remodeling processes [6,31]. 
α-SMA, a marker of myofibroblasts, determines 
the activity of fibroblasts and probably their 
number in different phases [32]. Fibroblasts 
overexpressing the extracellular matrix (ECM) 
components (such as collgen Type I, collagen 
Type III, fibronectin) play an important role in the 
formation of granulations within the tracheal wall, 
wound contraction and scar formation [7,32]. We 
can assume the obtained biopsy materials 
matches proliferation and mature phase, 
regarding the results of Cai et al. where authors 
observed the highest transforming growth factor 
(TGF)‑β, α-smooth muscle actin (α-SMA), type I 
and III collagen expression in the proliferation 
phase and mature phase [32].  
 
In the analysis of tissue specimens stained with 
hematoxylin and eosin, we found squamous 
metaplasia in all study subjects. Proliferating Ki-
67 (nuclear protein, necessary for cellular 
proliferation) positive cells were investigated and 
found mainly localized in the basal epithelial 
layer also with squamous epithelial metaplasia 
alltogether in most of the specimens [30], 
proposing the squamous metaplasia appears as 
a result of actively proliferating basal (stem) cells 
in epithelium, but specific inductor has not been 
found yet. Since the epithelium is exposed to the 
cuffed tube first, also the squamous metaplasia 
could appear first at the site of cuffed tube 




Fig. 4. Note the abundance of β defensin-2 positive epithelial cells (arrow) and n umerous  
β defensin-2 positive fibroblasts (arrow) in trachea l mucosa of 28 years old male.  













Fig. 5. Note ocassional IL-1-containing macrophages  (arrow) in tracheal submucosa  
of 70 years old male. IL-1 IMH, X 400 
 
the sequence of squamos metaplasia occuring 
before any other pathological events due to the 
findings of our study, where squamous 
metaplasia was found together with immune cell 
infiltration in all cases. Similar findings were 
found in the morphological analysis of iatrogenic 
subglottic tracheal stenosis mainly due to the 
long-term intubation [14]. In rabbit model, 
significant narrowing of the lumen occured due to 
the increase in submocasal thickness of tracheal 
stenosis induced by intubation [12,33]. In murine 
model, chemically and mechanically injured 
tracheal specimens showed either attenuated or 
regenerated epithelium within few pathological 
findings regarding fibrosis and granulations 
deeper in mucosa and submucosa [16].  
 
In our results, granulation tissue was present in 
tissue specimens of all patients involved in this 
study. Granulation tissue occured within various 
presentation – from few to moderate number of 
structural components found in both mucosal and 
submucosal layers. Besides the fibrosis found in 
part of tissue examples taken from patients with 
post-intubation tracheal stenosis, also the 
granulation tissue plays an important role in 
pathogenesis of tracheal stenosis and thus is 
related to the clinical and bronchoscopic findings. 
Granulation tissue and fibrosis shows complex 
and yet interacting wound healing seen in 
tracheal wall. Hypoxic conditions due to the 
ischemia caused by cuffed tube pressure on 
mucosa and submucosa in trachea is an 
important pathogenetic member. The expression 
of hypoxia-inducible factor (HIF)-1α (a nuclear 
transcription factor that facilitates the adaption of 
cells under hypoxic conditions) is seen highest in 
the granulation phase of the tracheal healing 
process, therefore suggesting HIF-1α may be a 
potential key regulator in both the initiation and 
facilitation of post-intubation tracheal stenosis 
pathogenesis [32]. Newly formed connective 
tissue, as well as rapid angiogenesis in 
granulation tissue may show the capabilities of 
healing and tissue remodelation instead of 
fibrous scarring (that could be seen as tissue 
replacement stage in damaged areas without 
further remodeling possibilities), and the at least 
partial renewal of previous structures at the 
wound site. Modified fibroblasts within the 
ingrowth of newly formated connective tissue are 
a characteristics of successful tracheal wall 
remodeling process.  
 
We found numerous immune cell (neutrofils, 
lymphocytes, macrophages) infiltration sites 
within mucosal and submucosal layers of 











cytokines IL-1α and TNFα in our study of post-
intubation tracheal stenosis affected patients 
briefly is characterised as weak, therefore we 
can assume the early inflammation part of wound 
healing ir replaced by further changes.  
 
Regarding wound healing cascade described by 
Hirshoren and Eliashar [15], we can assume our 
study findings show mostly the proliferation and 
maturation phase of wound-healing modulation 
processes in trachea, where massive cell 
proliferation within several cell types (fibroblasts, 
macrophages, keratinocytes and endothelial 
cells) Therefore, previous early release of 
inflammatory mediators (the most important, IL-1, 
TNFα) at the inflammation phase of wound 
healing cascade, cell migration of 
polymorphonuclear granulocytes (mostly 
neutrophils), monocytes, macrophages [15] was 
not observed in this study due to negative 
findings of active inflammation factors (none of 
IL-1 and TNF-α positive cells).  
 
The weak expression of pro-inflammatory 
cytokines within our study suggest that the 
initiatory part of occuring inflammation occured 
some time before the clinical signs (due to which 
the endoscopy was performed) appeared. TNFα 
and IL-1α was detected only in few scattered 
macrophages within mucosal and submucosal 
layers of tracheal wall, also fibrotic tissue was 
present. It is known, that IL-1 could induce the 
mitosis for smooth muscle cells and fibroblasts, 
thus it has has pro-fibrotic effects in many 
chronic inflammatory diseases.  Also several 
changes in immunological responses could be 
detected due to the release of IL-1 – increased 
antibody production (adjuvant effect), increased 
lymphokine synthesis (IL-1β, IL-2, -3, -4, -5, -6, -
7, -10, -12), enchanced development of T cell 
clones and other, also increased expression of 
various genes by IL-1 have been described: 
several cytokines, cytokine receptors, 
proinflammatory mediators, hepatic acute phase 
reactants, growth factors, clotting factors, tissue 
remodeling factors, components of extracellular 
matrix and other [20]. The IL-1α, one of the IL-1 
family cytokines, within the form of its precursor 
(pro IL-1α ) is present in all epithelial cell layers 
of the entire lung, endothelial cells. Upon cell 
death by necrosis, as occurs in ischemic 
diseases, the IL-1α precursor is released. 
Hypoxia, ischemia along with the reperfusion is 
know as inducers of IL-1. Furthermore, the IL-1α 
precursor rapidly initiates a cascade of 
inflammatory cytokines and chemokines. Another 
type – a membrane form of IL-1α – is seen on 
activated monocytes and B lymphocytes [19,20]. 
IL-1α also induces the release of IL-1β, which 
strongly amplifies the inflammation processes by 
recruiting macrophages [34], as well as induce 
the proliferation stage of wound healing cascade 
[15]. In the study by Haft et al. some cytokines 
were elevated – including IL-1β, IL-10, TNFα –, 
suggesting that symptomatic tracheal granulation 
tissue is mostly seen as the early inflammatory 
phase of wound healing, also the early fibrotic 
and angiogenesis remodeling processes could 
be described within detecting different cytokines 
[34].  
 
IL-10 was widely expressed in many cell types – 
starting from inflammatory cells (neutrophils, 
macrophages, lymphocytes) and continuing with 
epithelial cells, fibroblasts and modified 
fibroblasts (myofibroblasts), endothelial cells. 
The anti-inflammatory properties of IL-10 
persisted as normal response to the 
inflammation, suggesting the all cell types 
expressing IL-10 has sufficient sources of 
controling the immune response and maintaining 
the proliferation and maturation phases of wound 
healing. We hypothese, the early initiation of 
inflammatory processes, where IL-1 and TNFα 
work towards the intensifying the inflammation 
process, has been replaced by next stage of 
wound healing with, firstly, the modulating action, 
and afterwards an inhibiting abilities of anti-
inflammatory cytokines, particularly, IL-10. The 
cytokine IL-10 have several functions regarding 
inhibition of pro-inflammatory processes – it 
affects antigen presenting cells, supressing their 
ability to activate Th cells, as well as decreases 
the synthesis of IL-1β, IL-2, -4, -5, -6, -8, -12, 
particulary important, also TNF-α, thus working 
as anti-inflammatory cytokine [18,20,21].  
 
The expression of β def-2 was found as 
moderate to numerous positive structures 
located both in mucosa and submucosa – 
inflammatory cells, fibroblasts, epithelial cells – , 
also modified fibroblasts and glandulocytes of 
submucosal glands were found in one tissue 
specimens. We can hypothese the wide 
expression of β def-2 in outer structures, as well 
as in fibroblasts, inflammatory cells and 
endothelium of tracheal wall, suggest the tissue 
itself has activated its defense systems against 
potential inhalated antigenes, also show 
readiness to initiate immune responses to protect 
wounded tracheal wall. Due to the antimicrobic 
properties of β def-2 in the outermost respiratory 
tract parts (epithelium, glands with the secrete) 











environment full of different antigenes [35], we 
could suggest our β def-2 expression results 
show the antibacterial abilities of wounded 
tracheal wall that has been firstly induced by 
proinflammatory cytokines at first (mostly IL-1) 
[36], and afterall joined by wide expression 
throughout the tracheal wall.  
 
Assessing the results of our study, few limitations 
must be noted. In our study, biopsy specimens 
can not be analyzed within all layers of tracheal 
wall, as the tissue material using bronchoscopy 
could be taken only from upper surface of lining 
mucosa and submucosa. The exact interactions 
between native cells from different tissue found 
in tracheal wall and migrating inflammatory cells 
would be revealed performing the analysis of 
whole tracheal wall. Previous researches confirm 
the fibrotic changes or cicatrization through all 
tracheal layers, however, analysis of whole 
tracheal wall is not relevant to diagnostic 
observations in everyday clinical practice. We 
could speculate if fibrosis found only in mucosa 
and submucosa indicates fibrotic processes 
deeper in tracheal wall as well. Also the analysis 
of broader spectrum of pro- and anti-
inflammatory cytokines and other proteins in 
tracheal tissue could give more extensive 
understanding about the complex pathogenesis 
of post-intubation tracheal stenosis.  
 
The evaluation of morphological findings and 
detailed data about the healing stepways in 
wounded tracheal tissue obtained from patients 
with post-intubation tracheal stenosis could be 
adapted into multifactorial diagnostic tools along 
with the clinical and bronchoscopy data, as well 
as improve the classification systems and 
treatment options of post-intubation tracheal 
stenosis. Local expression of inflammatory 
factors may be predictive of outcome in patients 
treated for tracheal stenosis caused by 
prolonged intubation using cuffed tubes, 





The chronic inflammation with the formation of 
scarring tissue as a result of the previous 
formation of granulation tissue, as well as the 
remodeling of tracheal wall with the presence of 
fibroblasts and modified fibroblasts, also the 
ingrowth of connective tissue, assumedly, has 
the leading role in complex pathogenesis of post-
intubation  tracheal stenosis. 
The intense local tissue defense reactions are 
presented as compensatory expression of 
antimicrobial peptide β defensin-2 and anti-
inflammatory cytokine IL-10 found in different cell 
types within all tracheal wall layers.  
 
TNFα and IL-1 are not among the most 
significant factors in pathogenesis of PITS 
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